{"id":20,"date":"2026-08-17T12:53:22","date_gmt":"2026-08-17T12:53:22","guid":{"rendered":"https:\/\/peptide-doc.com\/learn\/sermorelin\/"},"modified":"2026-09-02T19:41:50","modified_gmt":"2026-09-02T19:41:50","slug":"sermorelin","status":"publish","type":"learn_article","link":"https:\/\/peptide-doc.com\/de\/learn\/sermorelin\/","title":{"rendered":"Sermorelin"},"content":{"rendered":"<div class=\"placeholder-meta\">\n<strong>META-TITLE:<\/strong> [TODO: Sermorelin \u2014 GHRH Analog Research Profile | Brand]<br \/>\n<strong>META-DESC:<\/strong> [TODO: Sermorelin research overview \u2014 GHRH(1-29) mechanism, GH secretion studies, dosing, safety, vs CJC\/Ipamorelin.]\n<\/div>\n<p><span class=\"todo\">[TODO]<\/span> Hook \u2014 sermorelin as the original synthetic GHRH analog, first FDA-approved GH secretagogue (1997), gateway compound for GH research<\/p>\n<div class=\"placeholder-img\">[IMAGE: Sermorelin molecular structure \u2014 29 amino acid GHRH fragment]<\/div>\n<h2>What is Sermorelin?<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Full name \u2014 Sermorelin acetate, GHRH(1-29)NH2<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Classification \u2014 Growth Hormone Releasing Hormone analog (first 29 AA of 44-AA GHRH)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> History \u2014 FDA approved 1997 for pediatric GH deficiency, discontinued 2008 (commercial)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Mechanism \u2014 stimulates anterior pituitary to release endogenous GH in pulsatile pattern<\/li>\n<\/ul>\n<h2>Mechanism of Action<\/h2>\n<div class=\"placeholder-img\">[IMAGE: Hypothalamic-pituitary-GH axis diagram showing where sermorelin acts]<\/div>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> GHRH receptor binding \u2014 anterior pituitary somatotrophs<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Pulsatile GH release \u2014 mimics natural secretion pattern (unlike exogenous GH)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> IGF-1 elevation \u2014 downstream hepatic IGF-1 production<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Negative feedback \u2014 preserved, prevents supraphysiological GH levels<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Short half-life \u2014 ~10-20 minutes, requires daily administration<\/li>\n<\/ul>\n<h2>Research Highlights<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> GH deficiency \u2014 restored GH secretion in pediatric and adult studies<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Body composition \u2014 increased lean mass, decreased fat mass in aging models<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Sleep quality \u2014 improved deep sleep \/ slow wave sleep (GH pulse timing)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Skin\/connective tissue \u2014 collagen synthesis improvement markers<\/li>\n<\/ul>\n<h2>Dosing Protocols (Research Context)<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Typical dose \u2014 100-300mcg\/day subcutaneous<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Timing \u2014 before bed (aligns with natural GH pulse) or morning fasted<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Cycle \u2014 3-6 months, with periodic IGF-1 monitoring<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Storage \u2014 lyophilized, reconstitute with BAC water, 2-8\u00b0C<\/li>\n<\/ul>\n<h2>Safety &amp; Considerations<\/h2>\n<ul>\n<li><span class=\"todo\">[TODO]<\/span> Well-tolerated \u2014 FDA-approved history supports safety profile<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Side effects \u2014 injection site reactions, headache, flushing (rare)<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Antibody formation \u2014 possible with long-term use, may reduce efficacy<\/li>\n<li><span class=\"todo\">[TODO]<\/span> Advantage \u2014 preserves natural feedback vs exogenous GH<\/li>\n<\/ul>\n<h2>Frequently Asked Questions<\/h2>\n<div class=\"placeholder-faq\">[FAQ: How does sermorelin differ from exogenous growth hormone?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: Why was sermorelin discontinued commercially?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: What time of day is best for administration?]<\/div>\n<div class=\"placeholder-faq\">[FAQ: How does sermorelin compare to CJC-1295?]<\/div>\n<h2>Related Products<\/h2>\n<p><span class=\"todo\">[TODO]<\/span> Link to Sermorelin product page + Growth Hormone category<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[META-DESC TODO: Sermorelin research profile \u2014 GHRH analog, growth hormone secretion, anti-aging research, dosing.]<\/p>\n","protected":false},"featured_media":0,"template":"","learn_category":[4],"class_list":["post-20","learn_article","type-learn_article","status-publish","hentry","learn_category-growth-hormone"],"_links":{"self":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/20","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article"}],"about":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/types\/learn_article"}],"version-history":[{"count":1,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/20\/revisions"}],"predecessor-version":[{"id":43,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_article\/20\/revisions\/43"}],"wp:attachment":[{"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/media?parent=20"}],"wp:term":[{"taxonomy":"learn_category","embeddable":true,"href":"https:\/\/peptide-doc.com\/de\/wp-json\/wp\/v2\/learn_category?post=20"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}